Details for New Drug Application (NDA): 021778
✉ Email this page to a colleague
The generic ingredient in MEGACE ES is megestrol acetate. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the megestrol acetate profile page.
Summary for 021778
Tradename: | MEGACE ES |
Applicant: | Endo Operations |
Ingredient: | megestrol acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021778
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 125MG/ML | ||||
Approval Date: | Jul 5, 2005 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021778
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Operations | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription